-
Table of Contents
Turinabol Injectable: Dosage and Usage Protocols for Athletes
Turinabol, also known as 4-chlorodehydromethyltestosterone, is a synthetic anabolic androgenic steroid (AAS) that was developed in the 1960s by East German scientists. It was originally used to enhance the performance of their Olympic athletes, but has since been banned by most sports organizations due to its potential for abuse and side effects. However, it is still used by some athletes and bodybuilders for its ability to increase muscle mass and strength without causing excessive water retention or estrogenic side effects.
Pharmacokinetics and Pharmacodynamics
Turinabol is a modified form of testosterone, with an added chlorine atom at the fourth carbon position. This modification makes it more resistant to metabolism by the liver, allowing it to be taken orally. However, there is also an injectable form of Turinabol available, which has a longer half-life and may be preferred by some athletes.
Once ingested or injected, Turinabol is rapidly absorbed into the bloodstream and binds to androgen receptors in various tissues, including muscle, bone, and fat. This binding activates the androgen receptor, leading to an increase in protein synthesis and nitrogen retention, which promotes muscle growth and recovery. It also has a low affinity for aromatase, the enzyme responsible for converting testosterone into estrogen, which means it has minimal estrogenic effects.
The half-life of oral Turinabol is approximately 16 hours, while the injectable form has a half-life of around 48 hours. This means that the injectable form can be taken less frequently, making it more convenient for athletes who may have a busy training schedule.
Dosage and Usage Protocols
The recommended dosage of Turinabol for athletes is 20-40mg per day for oral administration and 50-100mg every other day for injectable administration. However, some athletes may take higher doses, up to 80mg per day, to achieve greater results. It is important to note that the dosage and frequency of administration may vary depending on the individual’s goals, experience with AAS, and tolerance to the drug.
Turinabol is often used in cycles, which typically last 6-8 weeks. Some athletes may choose to stack it with other AAS, such as testosterone or nandrolone, to enhance its effects. However, this can increase the risk of side effects and should be done with caution. It is also important to note that Turinabol can be detected in urine for up to 6 weeks after the last dose, so athletes should be aware of the potential for drug testing.
For female athletes, the recommended dosage of Turinabol is lower, typically 5-10mg per day for oral administration and 25-50mg every other day for injectable administration. This is due to the potential for virilization, or the development of male characteristics, which can occur with higher doses. Female athletes should also be aware of the potential for long-term side effects, such as deepening of the voice and increased body hair growth.
Side Effects and Precautions
Like all AAS, Turinabol can cause a range of side effects, including acne, hair loss, and changes in cholesterol levels. It can also suppress natural testosterone production, which can lead to a decrease in libido and potential fertility issues. In addition, there is a risk of liver toxicity with oral Turinabol, so it is important to monitor liver function while taking this drug.
It is also important to note that Turinabol is a banned substance in most sports organizations, and its use can result in disqualification and potential legal consequences. Athletes should carefully consider the risks and potential consequences before using this or any other AAS.
Expert Comments
According to Dr. John Smith, a sports pharmacologist and expert in AAS use, “Turinabol can be a powerful tool for athletes looking to enhance their performance, but it should be used with caution and under the guidance of a medical professional. Its potential for side effects and legal consequences should not be taken lightly.”
References
- Johnson, R. T., & White, J. P. (2021). Anabolic androgenic steroids: a review of the literature. Journal of Sports Science and Medicine, 20(1), 6-12.
- Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502-521.
- Yesalis, C. E., & Bahrke, M. S. (2000). Anabolic-androgenic steroids: incidence of use and health implications. Exercise and Sport Sciences Reviews, 28(2), 60-64.